,dataset_name,cell_type,cell_type_ontology_id,donor_id,sex,race,development_stage,count,percentage
0,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",T cell,CL:0000084,SG_HEL_H249,female,Indian,43-year-old human stage,12,0.9623095429029671
1,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",platelet,CL:0000233,SG_HEL_H249,female,Indian,43-year-old human stage,12,0.9623095429029671
2,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",B cell,CL:0000236,SG_HEL_H249,female,Indian,43-year-old human stage,11,0.8821170809943866
3,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",monocyte,CL:0000576,SG_HEL_H249,female,Indian,43-year-old human stage,5,0.40096230954290296
4,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",natural killer cell,CL:0000623,SG_HEL_H249,female,Indian,43-year-old human stage,2,0.16038492381716118
5,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta T cell",CL:0000624,SG_HEL_H249,female,Indian,43-year-old human stage,29,2.3255813953488373
6,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta T cell",CL:0000625,SG_HEL_H249,female,Indian,43-year-old human stage,2,0.16038492381716118
7,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mature B cell,CL:0000785,SG_HEL_H249,female,Indian,43-year-old human stage,16,1.2830793905372895
8,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",memory B cell,CL:0000787,SG_HEL_H249,female,Indian,43-year-old human stage,67,5.3728949478749
9,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",naive B cell,CL:0000788,SG_HEL_H249,female,Indian,43-year-old human stage,156,12.510024057738573
10,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta cytotoxic T cell",CL:0000794,SG_HEL_H249,female,Indian,43-year-old human stage,62,4.971932638331997
11,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",gamma-delta T cell,CL:0000798,SG_HEL_H249,female,Indian,43-year-old human stage,46,3.6888532477947074
12,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",regulatory T cell,CL:0000815,SG_HEL_H249,female,Indian,43-year-old human stage,23,1.8444266238973537
13,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD4-positive, alpha-beta T cell",CL:0000895,SG_HEL_H249,female,Indian,43-year-old human stage,151,12.10906174819567
14,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD8-positive, alpha-beta T cell",CL:0000900,SG_HEL_H249,female,Indian,43-year-old human stage,70,5.613472333600641
15,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","central memory CD4-positive, alpha-beta T cell",CL:0000904,SG_HEL_H249,female,Indian,43-year-old human stage,123,9.863672814755413
16,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","effector memory CD4-positive, alpha-beta T cell",CL:0000905,SG_HEL_H249,female,Indian,43-year-old human stage,32,2.566158781074579
17,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta memory T cell",CL:0000909,SG_HEL_H249,female,Indian,43-year-old human stage,41,3.2878909382518042
18,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta cytotoxic T cell",CL:0000934,SG_HEL_H249,female,Indian,43-year-old human stage,8,0.6415396952686447
19,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-negative, CD56-bright natural killer cell, human",CL:0000938,SG_HEL_H249,female,Indian,43-year-old human stage,5,0.40096230954290296
20,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-positive, CD56-dim natural killer cell, human",CL:0000939,SG_HEL_H249,female,Indian,43-year-old human stage,134,10.7457898957498
21,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mucosal invariant T cell,CL:0000940,SG_HEL_H249,female,Indian,43-year-old human stage,31,2.4859663191659984
22,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD14-positive monocyte,CL:0001054,SG_HEL_H249,female,Indian,43-year-old human stage,143,11.467522052927025
23,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD14-low, CD16-positive monocyte",CL:0002396,SG_HEL_H249,female,Indian,43-year-old human stage,62,4.971932638331997
24,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD1c-positive myeloid dendritic cell,CL:0002399,SG_HEL_H249,female,Indian,43-year-old human stage,4,0.32076984763432237
